Lu, C., Yang, M., Huang, Z., Zheng, M., Li, Y., Zhang, Y., Zhang, H., Wu, Z., Wang, J., Zou, Z., Wang, J., Wang, F., Xu, C., Zhang, X., Yang, J., Huang, C., Ren, S., Zhou, Q. (2026). Amivantamab in
                    <i>EGFR</i>
                    -mutated NSCLC with refractory brain or leptomeningeal metastases: A multi-center real-world study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8521